tallimustine has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Animati, F; Bigioni, M; Lombardi, P; Manzini, S; Palma, C; Pratesi, G; Salvatore, C; Supino, R; Zunino, F | 1 |
| Ballinari, D; Barbieri, B; Biasoli, G; Capolongo, L; Giuliani, FC; Grandi, M; Mongelli, N; Pastori, A; Pesenti, E; Pezzoni, G | 1 |
2 other study(ies) available for tallimustine and Experimental Neoplasms
| Article | Year |
|---|---|
Cytotoxic and antitumor activity of MEN 10710, a novel alkylating derivative of distamycin.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Calcium Channel Blockers; Cell Survival; Distamycins; Humans; Leukemia L1210; Melphalan; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Neoplastic Stem Cells; Nitrogen Mustard Compounds; Organ Size; Tumor Cells, Cultured; Verapamil | 1997 |
Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Survival; Distamycins; In Vitro Techniques; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Nitrogen Mustard Compounds; Tumor Cells, Cultured | 1991 |